Table 2.
Respiratory outcomes and prognosis of infants undergoing NCPAP weaning with HFNC and room air groups.
| Item | Mean ± SD | p Value | |
|---|---|---|---|
| Weaned by HFNC (n = 46) | Weaned by Room Air (n = 87) | ||
| Length of Hospital Stay at Initiating NCPAP Weaning (days) | 48 ± 28 | 34 ± 26 | 0.004 * |
| PMA at Initiating NCPAP Weaning (weeks) | 35.6 ± 2.3 | 33.2 ± 2.5 | <0.001 * |
| Duration of Weaning from NCPAP to HFNC in HFNC group or to Room Air in Room Air Group (days) # | 7 ± 10 | 20 ± 11 | <0.001 * |
| PMA at Discontinuation of NCPAP (weeks) | 36.6 ± 3.0 | 36.1 ± 2.4 | 0.291 |
| Duration from Initiating NCPAP Weaning to Achieving Complete Room Air (days) | 30 ± 21 | 20 ± 11 | 0.003 * |
| Length of Hospital Stay (days) | 96 ± 38 | 78 ± 28 | 0.006 * |
| PMA at Discharge (weeks) | 42.4 ± 4.1 | 39.4 ± 2.6 | <0.001 * |
| Total Number of Days of Respiratory Therapy ^ | 80 ± 37 | 56 ± 25 | <0.001 * |
* p value < 0.05; ^ the total days of respiratory therapy support (included ventilator, NIPPV, NCPAP, HFNC) during admission; # the duration between starting weaning NCPAP and the discontinuation of NCPAP (days); NCPAP, nasal continuous positive airway pressure; HFNC, high-flow nasal cannula; PMA, post-menstrual age.